Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
The Journal of International Medical Research
|
June 27, 2020
Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial
Hyun-Sook Kim, Won-Ho Choi, Bo Young Kim, et al.
The Korean Journal of Internal Medicine
|
September 10, 2024
Effect of abatacept versus conventional synthetic disease modifying anti-rheumatic drugs on rheumatoid arthritis-associated interstitial lung disease
Kyung-Ann Lee, Bo Young Kim, Sung Soo Kim, et al.
Rheumatology International
|
September 7, 2015
Rheumatoid arthritis patients fulfilling Korean National Health Insurance reimbursement guidelines for anti-tumor necrosis factor-α treatment and comparison to other guidelines
Jin-Wuk Hur, Jung-Yoon Choe, Dong-Wook Kim, et al.
Diagnostics (Basel, Switzerland)
|
April 12, 2025
Impact of csDMARDs vs. b/tsDMARDs on the Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multicenter, Retrospective Study
Kyung-Ann Lee, Bo Young Kim, Sung Soo Kim, et al.
The Korean Journal of Internal Medicine
|
January 29, 2019
Simplified disease activity changes in real-world practice: a nationwide observational study of seropositive rheumatoid arthritis patients with moderate-to-high disease activity
Kichul Shin, Sung Soo Kim, Sang-Heon Lee, et al.
Gut and Liver
|
June 26, 2025
Comparing the Efficacy and Safety of Fexuprazan and Lansoprazole for the Prevention of Nonsteroidal Anti-inflammatory Drug-Induced Peptic Ulcer
Seokchan Hong, Ji Hyeon Ju, Sang-Heon Lee, et al.
Arthritis Research & Therapy
|
May 23, 2019
Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study
Min-Chan Park, Hiroaki Matsuno, Jinseok Kim, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
The Journal of International Medical Research
|
June 27, 2020
Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial
Hyun-Sook Kim, Won-Ho Choi, Bo Young Kim, et al.
The Korean Journal of Internal Medicine
|
September 10, 2024
Effect of abatacept versus conventional synthetic disease modifying anti-rheumatic drugs on rheumatoid arthritis-associated interstitial lung disease
Kyung-Ann Lee, Bo Young Kim, Sung Soo Kim, et al.
Rheumatology International
|
September 7, 2015
Rheumatoid arthritis patients fulfilling Korean National Health Insurance reimbursement guidelines for anti-tumor necrosis factor-α treatment and comparison to other guidelines
Jin-Wuk Hur, Jung-Yoon Choe, Dong-Wook Kim, et al.
Diagnostics (Basel, Switzerland)
|
April 12, 2025
Impact of csDMARDs vs. b/tsDMARDs on the Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multicenter, Retrospective Study
Kyung-Ann Lee, Bo Young Kim, Sung Soo Kim, et al.
The Korean Journal of Internal Medicine
|
January 29, 2019
Simplified disease activity changes in real-world practice: a nationwide observational study of seropositive rheumatoid arthritis patients with moderate-to-high disease activity
Kichul Shin, Sung Soo Kim, Sang-Heon Lee, et al.
Gut and Liver
|
June 26, 2025
Comparing the Efficacy and Safety of Fexuprazan and Lansoprazole for the Prevention of Nonsteroidal Anti-inflammatory Drug-Induced Peptic Ulcer
Seokchan Hong, Ji Hyeon Ju, Sang-Heon Lee, et al.
Arthritis Research & Therapy
|
May 23, 2019
Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study
Min-Chan Park, Hiroaki Matsuno, Jinseok Kim, et al.
Page
of 2